Treace Medical Concepts announced the successful completion of the first case using its Lapiplasty Lightning technology.

Lightning tech expands on the company’s Lapiplasty system with new instrumentation designed to reduce surgical steps, precisely correct in all three planes, and streamline procedural workflow with its SpeedPlate rapid compression fixation technology.

“As the pioneers and leaders in instrumented 3D bunion correction, Lightning technology demonstrates our commitment to continuous advancement of our patented Lapiplasty System, improving surgical efficiency and precision and expanding its appeal to more surgeons,” said John T. Treace, chairman and CEO of Treace. “We anticipate initiating our limited market release of the Lapiplasty Lightning System midyear 2026 in advance of full commercialization, which we expect before the end of year.”

The company recently highlighted new product innovations and presented new interim data for the ALIGN3D and MTA3D clinical studies at the American Orthopaedic Foot & Ankle Society (AOFAS) annual meeting.

“Lightning integrates years of clinical insights and feedback,” said William T. DeCarbo, DPM, of Greater Pittsburgh Foot & Ankle Center and a member of Treace’s surgeon advisory board. “I found the instrumentation highly intuitive, allowing me to perform a faster Lapiplasty Procedure while also providing greater accuracy and control of the 3-plane correction. Having the instrumentation hold the correction from the start of the case through application of fixation, without the need for provisional fixation, simplifies and streamlines my surgical workflow.”